Minimal Hepatic Encephalopathy in Patients with Cirrhosis Using Psychometric Hepatic Encephalopathy Score Tests: Minimal Hepatic Encephalopathy with Psychometric Hepatic Encephalopathy Score

Humaira Zakir; Amanullah Khokar; Waqas Manzoor; Habiba Aman; Mariam Fatima Waqar; Abdul Majid; Hina Khan

doi:10.54393/pjhs.v6i6.3262

Authors

Humaira Zakir Department of Medicine, Al Tibri Medical College and Hospital, Isra University, Karachi, Pakistan
Amanullah Khokar Department of Medicine, Al Tibri Medical College and Hospital, Isra University, Karachi, Pakistan
Waqas Manzoor Department of Gastrology, Al Tibri Medical College and Hospital, Isra University, Karachi, Pakistan
Habiba Aman Department of Medicine, Al Tibri Medical College and Hospital, Isra University, Karachi, Pakistan
Mariam Fatima Waqar Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
Abdul Majid Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan
Hina Khan Al-Tibri Medical College and Hospital, Isra University, Karachi, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v6i6.3262

Keywords:

Liver Cirrhosis, Minimal Hepatic Encephalopathy, Psychometric Hepatic Encephalopathy Score, Cognitive Ability

Abstract

Minimal hepatic encephalopathy (MHE) is defined as changes in cognitive ability, electrophysiology, and homeostasis of neurotransmission and blood flow in the cerebrum. It is observed in patients with chronic liver disease and cirrhosis who do not have clinical features of overt hepatic encephalopathy. The International Society for Hepatic Encephalopathy and Nitrogen recommend the Psychometric Hepatic Encephalopathy Score (PHES) to easily detect and treat these patients. Objectives: To calculate the frequency of MHE amongst patients with cirrhosis of the liver based on the Psychometric Hepatic Encephalopathy Score. Methods: This cross-sectional study was conducted at the Department of Medicine, Al Tibri Medical College, Karachi. A total of 235 patients with cirrhosis of the liver with normal mental status were included. Patients were given 5 printed sheets of paper, one each for the number connection test A and test B, line tracing, serial dotting test and digit symbol test. A score of two or less was labelled as minimal hepatic Encephalopathy. Chi-square test was applied for checking the association, and a p-value≤0.05 was considered significant. Results: There were 62.13% male and 37.87% female. The mean age was 45.47 ± 13.28 years. The mean duration of cirrhosis was 5.54 ± 3.7 years. Most of the patients (53.6%) successfully performed four and five PHES tests, while 22.13% patients successfully performed three tests. 15.32% and 8.94% were successfully performed two and one PHES test, respectively. Minimal hepatic encephalopathy was observed in 24.68% cases. Conclusions: It was concluded that the PHES is easily detected and can treat minimal hepatic encephalopathy.

References

Butterworth RF. Hepatic encephalopathy in cirrhosis: pathology and pathophysiology. Drugs. 2019 Feb; 79(Suppl 1): 17-21. doi: 10.1007/s40265-018-1017-0.

Shetty A, Saab EG, Choi G. Social impact of hepatic Encephalopathy. Clinics in Liver Disease. 2024 May; 28(2): 273-85.

Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014 Aug; 60(2): 715-35.

Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD et al. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. Journal of Hepatology. 2020 Dec; 73(6): 1526-47. doi: 10.1016/j.jhep.2020.07.013.

Weissenborn K. Hepatic encephalopathy: definition, clinical grading and diagnostic principles. Drugs. 2019 Feb; 79(Suppl 1): 5-9. doi: 10.1007/s40265-018-1018-z.

Rathi S, Chopra M, Chouduri G, Sharma P, Madan K, Chhabra M et al. Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a cross-sectional, clinic-epidemiological, multicenter, nationwide study in India: the PREDICT study. Journal of Clinical and Experimental Hepatology. 2019 Jul; 9(4): 476-83. doi: 10.1016/j.jceh.2018.09.009.

San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P et al. Motor and cognitive performance in patients with liver cirrhosis with minimal hepatic encephalopathy. Journal of Clinical Medicine. 2020 Jul 8; 9(7): 2154. doi: 10.3390/jcm9072154.

Tejpal S, Sharma SK, Sharma A, Sharma S. A comprehensive review on hepatic encephalopathy: pathophysiology, symptoms, epidemiology, classification, diagnosis and treatment. Journal for Research in Applied Sciences and Biotechnology. 2024; 3(3): 170-80. doi: 10.55544/jrasb.3.3.27.

Amodio P and Montagnese S. Lights and shadows in hepatic encephalopathy diagnosis. Journal of Clinical Medicine. 2021 Jan; 10(2): 341. doi: 10.3390/jcm10020341.

Bajaj JS, Gentili A, Wade JB, Godschalk M. Specific challenges in geriatric cirrhosis and hepatic encephalopathy. Clinical Gastroenterology and Hepatology. 2022 Aug; 20(8): S20-9. doi: 10.1016/j.cgh.2022.04.035.

Duarte-Rojo A, Allampati S, Thacker LR, Flud CR, Patidar KR, White MB et al. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing. Metabolic Brain Disease. 2019 Feb; 34: 289-95. doi: 10.1007/s11011-018-0350-z.

Lauridsen MM, Grønkjær LL, Atkins JH, Mikkelsen SU, Svensson T, Kimer N et al. Portosystemic Hepatic Encephalopathy Scores (PHES) differ between Danish and German healthy populations despite their geographical and cultural similarities. Metabolic Brain Disease. 2024 Aug; 39(6): 1149-55. doi: 10.1007/s11011-024-01380-1.

Ehrenbauer AF, Egge JF, Al-Ayoubi J, Hennemann AK, Dirks M, Wedemeyer H et al. P26 Reevaluation of the Critical Flicker Frequency in Patients with Liver Cirrhosis Reveals New Perspectives of Its Diagnostic Impact in the Detection of Hepatic Encephalopathy. Official journal of the American College of Gastroenterology. 2023 Sep; 118(9S): S19-20. doi: 10.14309/01.ajg.0000948388.78047.31.

Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic encephalopathy: diagnosis and management. Journal of Translational Internal Medicine. 2020 Dec; 8(4): 210-9. doi: 10.2478/jtim-2020-0034.

Moran S, López-Sánchez M, del Pilar Milke-García M, Rodríguez-Leal G. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. World Journal of Gastroenterology. 2021 Jun; 27(22): 3050. doi: 10.3748/wjg.v27.i22.3050.

Karanfilian BV, Park T, Senatore F, Rustgi VK. Minimal hepatic encephalopathy. Clinics in Liver Disease. 2020 Mar; 24(2): 209-18. doi: 10.1016/j.cld.2020.01.012.

Torres DS, Abrantes J, Brandão-Mello CE. Cognitive and neurophysiological assessment of patients with minimal hepatic encephalopathy in Brazil. Scientific Reports. 2020 May; 10(1): 8610. doi: 10.1038/s41598-020-65307-3.

Maldonado-Garza HJ, Vázquez-Elizondo G, Gaytán-Torres JO, Flores-Rendón ÁR, Cárdenas-Sandoval MG, Bosques-Padilla FJ. Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Annals of Hepatology. 2016 Apr; 10(S2): 40-4.

Li SW, Wang K, Yu YQ, Wang HB, Li YH, Xu JM. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World Journal of Gastroenterology. 2013 Dec; 19(46): 8745. doi: 10.3748/wjg.v19.i46.8745.

Tapper EB, Parikh ND, Waljee AK, Volk M, Carlozzi NE, Lok AS. Diagnosis of minimal hepatic encephalopathy: a systematic review of point-of-care diagnostic tests. Official Journal of the American College of Gastroenterology. 2018 Apr; 113(4): 529-38. doi: 10.1038/ajg.2018.6.

Hansen MK, Kjærgaard K, Eriksen LL, Grønkjær LL, Mikkelsen AC, Sandahl TD et al. Psychometric methods for diagnosing and monitoring minimal hepatic encephalopathy—current validation level and practical use. Metabolic Brain Disease. 2022 Mar; 37(3): 589-605. doi: 10.1007/s11011-022-00913-w.

Gairing SJ, Mangini C, Zarantonello L, Jonasson E, Danneberg S, Sultanik P et al. PHES scores have limited impact on the risk of overt HE in patients with minimal HE. Hepatology Communications. 2024 May; 8(5): e0438. doi: 10.1097/HC9.0000000000000438.

Thanapirom K, Wongwandee M, Suksawatamnuay S, Thaimai P, Siripon N, Makhasen W et al. Psychometric hepatic encephalopathy score for the diagnosis of minimal hepatic encephalopathy in Thai cirrhotic patients. Journal of Clinical Medicine. 2023 Jan; 12(2): 519. doi: 10.3390/jcm12020519.

Gairing SJ, Mangini C, Zarantonello L, Gioia S, Nielsen EJ, Danneberg S, Gabriel M, Ehrenbauer AF, Bloom PP, Ripoll C and Sultanik P. Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a multicenter study. Official Journal of the American College of Gastroenterology. 2023 Dec; 118(12): 2191-200. doi: 10.14309/ajg.0000000000002251.

Elgohary MN, Amer K, Bassiony MA. Prevalence and risk factors of minimal hepatic encephalopathy in patients with compensated liver cirrhosis. The Egyptian Journal of Hospital Medicine. 2020 Jul; 80(2): 871-5. doi: 10.21608/ejhm.2020.100204.